reports
- ING Helpdesk
Benelux Morning Notes
AB InBev: $3bn in the can; Aedifica: €108.5m investments at a 6-7% yield; Kinepolis: December US box office revenue down 2%, France visitors up 1%, Avatar below expectations; TomTom: Starting the year with CES fireworks; WDP: €58m investment in Le Havre and €35m disposal in Liège.
- Jacob Mekhael
- Lynn Hautekeete
- Mathijs Geerts Danau
- Wim Hoste
- Wim Lewi
Progress on share buyback programme
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 1,390,645 shares were repurchased during the week of 29 December up to and including 2 January 2026. The shares were repurchased at an average price of €24.00 for a total amount of €33,375,275.28. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the updates on the on our website. In line with the purpose of the programme to reduce...
Arcadis reports transactions under its current share buyback program
Arcadis reports transactions under its current share buyback program PRESS RELEASEArcadis reports transactions under its current share buyback program Amsterdam, 6 January 2026 – Arcadis N.V. (Arcadis), the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, repurchased 246,237 of its own shares in the period 29 December 2025 – 2 January 2026 at an average price of €35.73. The total consideration of this repurchase was €8,798,027. The total number of shares repurchased under this program to date is 3,680,...
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
argenx to Present at 44th Annual J.P. Morgan Healthcare Conference January 6, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. PT. A live webcast of the presentation may be accessed on the Investors section of the argenx website at . A replay of the webcast will be available on the argenx...
ING determines cash payment per share as part of current distribution
ING determines cash payment per share as part of current distribution ING determines cash payment per share as part of current distribution ING announced today that it will pay €0.172 per share on 15 January 2026, as part of the up to €1.6 billion distribution to shareholders as announced on 30 October 2025. The amount per share has been determined based on the total cash payment of €500 million and the 2,902 million ordinary shares outstanding on 31 December 2025. Next to the cash payment, the distribution also consists of a share buyback programme of up to €1.1 billion which is current...
- Hilde Van Boxstael
- Jacob Mekhael
- Livio Luyten
- Lynn Hautekeete
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
argenx Karen Massey to become new CEO
argenx announced that Karen Massey, current COO, will transition to CEO and executive director and Tim Van Hauwermeiren, current CEO, will transition to non-executive director and chairman of the board. We believe Karen is a strong fit for the CEO role as an internal candidate who, in her capacity as COO, helped shape the company's Vision 2030 and built its commercial engine. Based on our conversation with management, Karen will focus on ensuring continuity and executing argenx' strategy, while...
- Marc Zwartsenburg
- CEFA
ING Benelux Favourites/Weekly performance and valuation update
We update the performance of our ING Benelux Favourites list as well as all valuation and ranking tables for our coverage universe. Performance on the front page is dated from the 19 September 2025, while historical performance is included on the second page. The methodology for our favourites selection is based on a bottom-up approach with a focus on absolute performance with clear near-term triggers. It is a rolling list, ie, stocks can enter/exit whenever we think opportune.
argenx Announces Leadership Transition Marking Next Evolution of Growt...
argenx Announces Leadership Transition Marking Next Evolution of Growth Tim Van Hauwermeiren to transition from CEO to Non-Executive Director and Chairman of Board of Directors and Karen Massey to transition from COO to CEO and Executive Director January 5, 2026 7:00 a.m. CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, current Chief Operating Officer, will transition to Chief Executive Officer and Executive Director an...
- Felix Fischer
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Si Yong Ng
- Tanvi Arora
- Trung Nguyen
Lucror Analytics - Morning Views Europe
In today's Morning Views publication we comment on developments of the following high yield issuers: Oriflame, Samvardhana Motherson, Telecom Italia, International Personal Finance, Novelis, Intrum, Nexans, Italmatch Chemicals, Asmodee, Lecta, Hapag-Lloyd, Ontex, Modulaire, Vedanta Resources, Softbank Group, Teva
Téléperformance : Evolution of coverage
Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Teleperformance : Evolution of coverage
Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Progress on share buyback programme
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 956,622 shares were repurchased during the week of 22 December up to and including 26 December 2025. The shares were repurchased at an average price of €23.87 for a total amount of €22,836,208.09. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capi...
Arcadis reports transactions under its current share buyback program
Arcadis reports transactions under its current share buyback program PRESS RELEASEArcadis reports transactions under its current share buyback program Amsterdam, 30 December 2025 – Arcadis N.V. (Arcadis), the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, repurchased 222,629 of its own shares in the period 22 – 26 December 2025 at an average price of €35.20. The total consideration of this repurchase was €7,836,370. The total number of shares repurchased under this program to date is 3,434,090 shares...
- Carole Braudeau
- Carole Braudeau
Progress on share buyback programme
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 1,974,051 shares were repurchased during the week of 15 December up to and including 19 December 2025. The shares were repurchased at an average price of €23.54 for a total amount of €46,459,433.76. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share ca...
Arcadis reports transactions under its current share buyback program
Arcadis reports transactions under its current share buyback program PRESS RELEASEArcadis reports transactions under its current share buyback program Amsterdam, 23 December 2025 – Arcadis N.V. (Arcadis), the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, repurchased 413,279 of its own shares in the period 15 – 19 December 2025 at an average price of €36.07. The total consideration of this repurchase was €14,908,703. The total number of shares repurchased under this program to date is 3,211,1461 shar...
Ontex Group NV: 1 director
A director at Ontex Group NV bought 5,000 shares at 4.630EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.